In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including ...

Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

Learn more about whether Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. is a better investment based on AAII ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

What if the same Bitcoin signature could authorize spending from multiple different UTXOs? BIP 118's ANYPREVOUT does exactly ...

An updated edition of the May 18, 2026, article. The global oncology market is evolving rapidly, fueled by rising cancer incidence, an aging population and continued scientific innovation. According ...

Vitalik Buterin outlined the updated Lean Ethereum roadmap, a 3-to-4-year plan covering quantum resistance, 10,000 TPS ...

Chinese open-weight artificial intelligence (AI) models are gaining ground among organisations in Singapore as lower costs and the ability to run the models in their own environments win over ...

Silverfort's Copilot Studio integration secures AI agents with runtime identity & access controls, accelerating safe adoption of agentic AI DALLAS, June 8, 2026 /PRNewswire/ -- Silverfort, an Identity ...

Nous Research has released Hermes Mixture of Agents 2.0 (MoA 2.0), an update to its open-source Hermes Agent framework that ...